Melphalan

Overview

Melphalan is a bifunctional alkylating agent used in the treatment of multiple myeloma and other types of cancer. It works by causing cross-links in the DNA, leading to cell death.

API suppliers (2)

Suppliers of Melphalan backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CHEMWERTH INC1 active DMF
• XIAN LIBANG PHARMACEUTICAL CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (15 approved US products), the latest listed US patent on Melphalan expires 28 Jun 2036 and exclusivity 13 Aug 2030. Generic API sourcing typically opens up once these lapse.

Therapeutic areas